Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

published : This year    symbols : SNY    save search

Sobi Q1 2024 report: Strong sales reflecting the strength of the portfolio
Published: 2024-04-25 (Crawled : 08:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310 twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
SNY | News | $46.61 -2.27% -2.21% 1.6M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

sales
Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance
Published: 2024-04-25 (Crawled : 06:00) - globenewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 310 twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
SNY | News | $46.61 -2.27% -2.21% 1.6M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

sales sanofi growth
Dassault Systèmes Reports Solid First Quarter Results And Reaffirms Full-Year Objectives
Published: 2024-04-25 (Crawled : 05:00) - globenewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 310 twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
SNY | News | $46.61 -2.27% -2.21% 1.6M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

first results
Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
Published: 2024-04-25 (Crawled : 02:00) - prnewswire.com
SNY | News | $46.61 -2.27% -2.21% 1.6M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
SNYNF | News | $94.0 -0.27% -2.18% 310 twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

asco meeting
First Approval for Rare Pediatric Cancer; New OTC Opioid Overdose Option
Published: 2024-04-24 (Crawled : 16:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310 twitter stocktwits trandingview |
Health Technology
| | O: 0.8% H: 0.0% C: -1.05%
PRGO | $31.23 2.43% 0.0% 960K twitter stocktwits trandingview |
Health Technology
| | O: 0.1% H: 0.0% C: 0.0%
JNJ | News | $148.53 -0.69% 0.18% 7.5M twitter stocktwits trandingview |
Health Technology
| | O: -1.02% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% 0.07% 4.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.82% H: 0.37% C: 0.17%
XOMA | $25.64 -1.73% -3.9% 8.2K twitter stocktwits trandingview |
Health Technology
| | O: 0.19% H: 0.0% C: -1.91%
SNY | News | $46.61 -2.27% -2.21% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.82% H: 0.0% C: 0.0%

rare first opioid approval for
CureVac Appoints Thaminda Ramanayake as New Chief Business Officer
Published: 2024-04-24 (Crawled : 15:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310 twitter stocktwits trandingview |
Health Technology
| | O: 0.8% H: 0.0% C: -1.05%
JNJ | News | $148.53 -0.69% 0.18% 7.5M twitter stocktwits trandingview |
Health Technology
| | O: -1.02% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.82% H: 0.0% C: 0.0%
CVAC | $2.51 -3.46% -3.59% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: -4.62% H: 4.44% C: 1.21%

business
Lantern Pharma Launches “Webinar Wednesdays” Featuring World-Class Physician Scientists & Key Opinion Leaders Discussing Critical Areas of Oncology Drug Development
Published: 2024-04-24 (Crawled : 14:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310 twitter stocktwits trandingview |
Health Technology
| | O: 0.8% H: 0.0% C: -1.05%
SNY | News | $46.61 -2.27% -2.21% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.82% H: 0.0% C: 0.0%
LTRN | News | $5.38 -6.76% -6.07% 98K twitter stocktwits trandingview |
Health Technology
| | O: 1.21% H: 2.91% C: -7.88%

pharma drug key leaders development
Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO
Published: 2024-04-24 (Crawled : 14:00) - globenewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 310 twitter stocktwits trandingview |
Health Technology
| | O: 0.8% H: 0.0% C: -1.05%
SNY | News | $46.61 -2.27% -2.21% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.82% H: 0.0% C: 0.0%
REGN | News | $906.54 -0.09% -0.08% 280K twitter stocktwits trandingview |
Health Technology
| | O: -0.05% H: 0.97% C: -0.04%

asco tumors treatment blood for
Sanofi Layoffs, CAR-T Warnings and a New GLP-1 Player
Published: 2024-04-24 (Crawled : 13:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310 twitter stocktwits trandingview |
Health Technology
| | O: 0.8% H: 0.0% C: -1.05%
SNY | News | $46.61 -2.27% -2.21% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.82% H: 0.0% C: 0.0%

car-t sanofi
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update
Published: 2024-04-24 (Crawled : 13:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310 twitter stocktwits trandingview |
Health Technology
| | O: 0.8% H: 0.0% C: -1.05%
SNY | News | $46.61 -2.27% -2.21% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.82% H: 0.0% C: 0.0%
CVAC | $2.51 -3.46% -3.59% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: -4.62% H: 4.44% C: 1.21%
BNTX | News | $88.09 -0.45% -0.35% 230K twitter stocktwits trandingview |
Health Technology
| | O: 0.11% H: 0.97% C: -0.56%

business update for financial results
Biopharma Layoff Tracker 2024: Tessera, BMS, Pfizer and More Cut Staff
Published: 2024-04-24 (Crawled : 12:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310 twitter stocktwits trandingview |
Health Technology
| | O: 0.8% H: 0.0% C: -1.05%
RLYB | News | $1.58 -9.2% -9.43% 250K twitter stocktwits trandingview |
| | O: -3.05% H: 0.0% C: -9.71%
JNJ | News | $148.53 -0.69% 0.18% 7.5M twitter stocktwits trandingview |
Health Technology
| | O: -1.02% H: 0.0% C: 0.0%
VXRT | News | $0.7097 -4.79% -5.72% 1.4M twitter stocktwits trandingview |
Health Technology
| | O: -1.94% H: 0.0% C: -6.58%
TXMD | News | $1.92 2.13% -0.27% 15K twitter stocktwits trandingview |
Health Technology
| | O: 0.53% H: 2.12% C: 1.59%
SNY | News | $46.61 -2.27% -2.21% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.82% H: 0.0% C: 0.0%
PTCT | News S | $25.21 -0.79% -0.87% 560K twitter stocktwits trandingview |
Health Technology
| | O: -0.71% H: 0.81% C: -2.25%
NKTR | News | $1.38 -2.82% -2.16% 960K twitter stocktwits trandingview |
Health Technology
| | O: -1.08% H: 3.65% C: 0.73%
MOR | News | $18.05 0.06% 0.17% 130K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.28% C: 0.06%
GLPG | News | $28.77 -2.31% -2.33% 130K twitter stocktwits trandingview |
Health Technology
| | O: 0.48% H: 0.17% C: -1.88%
AMRN | News | $0.8786 -0.53% 0.12% 640K twitter stocktwits trandingview |
Health Technology
| | O: 0.57% H: 1.14% C: 0.0%
GOOGL | News 4 | $159.13 0.55% 0.58% 18M twitter stocktwits trandingview |
Technology Services
| | O: 0.29% H: 1.31% C: 1.04%
GOOG | News 4 | $161.1 0.74% 0.7% 16M twitter stocktwits trandingview |
Technology Services
| | O: 0.32% H: 1.45% C: 1.26%
OCX | News | $2.46 0.2% -6.74% 40K twitter stocktwits trandingview |
Health Technology
| | O: 2.03% H: 0.0% C: -1.99%

biopharma
Biopharma Layoff Tracker 2024: Tessera, BenevolentAI, Pfizer and More Cut Staff
Published: 2024-04-24 (Crawled : 05:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310 twitter stocktwits trandingview |
Health Technology
| | O: 0.8% H: 0.0% C: -1.05%
RLYB | News | $1.58 -9.2% -9.43% 250K twitter stocktwits trandingview |
| | O: -3.05% H: 0.0% C: -9.71%
JNJ | News | $148.53 -0.69% 0.18% 7.5M twitter stocktwits trandingview |
Health Technology
| | O: -1.02% H: 0.0% C: 0.0%
VXRT | News | $0.7097 -4.79% -5.72% 1.4M twitter stocktwits trandingview |
Health Technology
| | O: -1.94% H: 0.0% C: -6.58%
TXMD | News | $1.92 2.13% -0.27% 15K twitter stocktwits trandingview |
Health Technology
| | O: 0.53% H: 2.12% C: 1.59%
SNY | News | $46.61 -2.27% -2.21% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.82% H: 0.0% C: 0.0%
PTCT | News S | $25.21 -0.79% -0.87% 560K twitter stocktwits trandingview |
Health Technology
| | O: -0.71% H: 0.81% C: -2.25%
NKTR | News | $1.38 -2.82% -2.16% 960K twitter stocktwits trandingview |
Health Technology
| | O: -1.08% H: 3.65% C: 0.73%
MOR | News | $18.05 0.06% 0.17% 130K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.28% C: 0.06%
GLPG | News | $28.77 -2.31% -2.33% 130K twitter stocktwits trandingview |
Health Technology
| | O: 0.48% H: 0.17% C: -1.88%
AMRN | News | $0.8786 -0.53% 0.12% 640K twitter stocktwits trandingview |
Health Technology
| | O: 0.57% H: 1.14% C: 0.0%
GOOGL | News 4 | $159.13 0.55% 0.58% 18M twitter stocktwits trandingview |
Technology Services
| | O: 0.29% H: 1.31% C: 1.04%
GOOG | News 4 | $161.1 0.74% 0.7% 16M twitter stocktwits trandingview |
Technology Services
| | O: 0.32% H: 1.45% C: 1.26%
OCX | News | $2.46 0.2% -6.74% 40K twitter stocktwits trandingview |
Health Technology
| | O: 2.03% H: 0.0% C: -1.99%

biopharma
Curio Digital Therapeutics Inc. Announces the U.S. Food and Drug Administration (FDA) Clearance of MamaLift Plus™, the First Prescription Digital Therapeutic Authorized for the Treatment of Postpartum Depression (PPD)
Published: 2024-04-23 (Crawled : 00:00) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 1.7% H: 0.0% C: 0.0%

first drug authorized food depression treatment clearance for therapeutics
Biopharma Layoff Tracker 2024: BenevolentAI, Pfizer, Sanofi and More Cut Staff
Published: 2024-04-23 (Crawled : 14:30) - biospace.com/
RLYB | News | $1.58 -9.2% -9.43% 250K twitter stocktwits trandingview |
| | O: 1.98% H: 0.0% C: 0.0%
JNJ | News | $148.53 -0.69% 0.18% 7.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.89% H: 0.0% C: 0.0%
VXRT | News | $0.7097 -4.79% -5.72% 1.4M twitter stocktwits trandingview |
Health Technology
| | O: 1.97% H: 0.0% C: 0.0%
TXMD | News | $1.92 2.13% -0.27% 15K twitter stocktwits trandingview |
Health Technology
| | O: -0.53% H: 1.07% C: 0.53%
SNY | News | $46.61 -2.27% -2.21% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 1.7% H: 0.0% C: 0.0%
PTCT | News S | $25.21 -0.79% -0.87% 560K twitter stocktwits trandingview |
Health Technology
| | O: 0.02% H: 0.0% C: 0.0%
NKTR | News | $1.38 -2.82% -2.16% 960K twitter stocktwits trandingview |
Health Technology
| | O: 1.84% H: 0.0% C: 0.0%
MOR | News | $18.05 0.06% 0.17% 130K twitter stocktwits trandingview |
Health Technology
| | O: 0.39% H: 0.0% C: 0.0%
GLPG | News | $28.77 -2.31% -2.33% 130K twitter stocktwits trandingview |
Health Technology
| | O: 0.38% H: 0.0% C: 0.0%
AMRN | News | $0.8786 -0.53% 0.12% 640K twitter stocktwits trandingview |
Health Technology
| | O: 0.57% H: 0.0% C: 0.0%
GOOGL | News 4 | $159.13 0.55% 0.58% 18M twitter stocktwits trandingview |
Technology Services
| | O: 0.48% H: 0.0% C: 0.0%
GOOG | News 4 | $161.1 0.74% 0.7% 16M twitter stocktwits trandingview |
Technology Services
| | O: 0.41% H: 0.0% C: 0.0%
OCX | News | $2.46 0.2% -6.74% 40K twitter stocktwits trandingview |
Health Technology
| | O: -1.99% H: 0.0% C: 0.0%

biopharma sanofi
Response Pharmaceuticals’ Drug Candidate for the Treatment of Antipsychotic-Induced Weight Gain (AIWG) Achieves Primary Endpoint in Phase 1b Clinical Trial
Published: 2024-04-23 (Crawled : 14:30) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 1.7% H: 0.0% C: 0.0%

drug candidate treatment for trial response
FDA Rejects Abeona’s Gene Therapy, Approves ImmunityBio’s Bladder Cancer Treatment
Published: 2024-04-23 (Crawled : 13:30) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K twitter stocktwits trandingview |
Health Technology
| | O: 0.13% H: 1.89% C: 1.3%
JNJ | News | $148.53 -0.69% 0.18% 7.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.89% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% 0.07% 4.2M twitter stocktwits trandingview |
Health Technology
| | O: 0.56% H: 0.41% C: -0.07%
SNY | News | $46.61 -2.27% -2.21% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 1.7% H: 0.0% C: 0.0%

fda bladder cancer treatment
Sanofi’s $3.7B Principia Buy Starts to Pay Off with Phase III Rilzabrutinib Win
Published: 2024-04-23 (Crawled : 13:30) - biospace.com/
SNY | News | $46.61 -2.27% -2.21% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 1.7% H: 0.0% C: 0.0%


Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
Published: 2024-04-23 (Crawled : 05:00) - globenewswire.com
SNY | News | $46.61 -2.27% -2.21% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 1.7% H: 0.0% C: 0.0%

study
Over-The-Counter Drug Market size is set to grow by USD 58.54 billion from 2023-2027, Abbott Laboratories, Achelios Therapeutics Inc. and AstraZeneca Plc, and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-04-22 (Crawled : 22:00) - prnewswire.com
RBGPF | News | $53.94 3.53% 6.46% 3.4K twitter stocktwits trandingview |
Consumer Non-Durables
| | O: 0.98% H: 5.46% C: -0.89%
GLAXF | News | $19.54 -3.77% -14.18% 170 twitter stocktwits trandingview |
Health Technology
| | O: -3.15% H: 0.0% C: -0.61%
AZNCF | News | $135.35 -3.53% -4.19% 400 twitter stocktwits trandingview |
Health Technology
| | O: 0.96% H: 2.38% C: 0.17%
NVSEF | News | $96.0 0.94% 6.88% 0 twitter stocktwits trandingview |
Health Technology
| | O: 1.69% H: 0.02% C: -0.74%
RBGLY | News | $10.98 2.0% -2.05% 860K twitter stocktwits trandingview |
Manufacturing
| | O: -0.28% H: 2.18% C: 1.99%
NVS | News | $98.35 1.1% 0.69% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 4.32% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% 1.25% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.17% H: 1.48% C: 1.43%
ABT | News | $106.89 -0.65% 0.07% 4.2M twitter stocktwits trandingview |
Health Technology
| | O: 0.56% H: 0.41% C: -0.07%
SNY | News | $46.61 -2.27% -2.21% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 1.7% H: 0.0% C: 0.0%
AZN | News | $71.2 0.49% 0.46% 5.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.4% H: 0.0% C: 0.0%

drug astrazeneca set key therapeutics market
Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Therapy (ASGCT)
Published: 2024-04-22 (Crawled : 22:00) - globenewswire.com
SNY | News | $46.61 -2.27% -2.21% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 1.7% H: 0.0% C: 0.0%
REGN | News | $906.54 -0.09% -0.08% 280K twitter stocktwits trandingview |
Health Technology
| | O: 0.51% H: 0.78% C: 0.18%

genetic cell research therapy
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M twitter stocktwits trandingview |
Consumer Services

BOF | $2.08 77.78% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.54 12.27% 40.62% 3.7M twitter stocktwits trandingview |

LICN | $0.999 78.39% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.4 70.0% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.6 60.71% 38.04% 9.1M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.458 14.5% 30.92% 91K twitter stocktwits trandingview |
Health Services

WHLM | $6.25 35.87% 28.46% 700K twitter stocktwits trandingview |
Commercial Services

MULN | News | $3.77 38.1% 27.78% 13M twitter stocktwits trandingview |
Information


Your saved searches
Save your searches and get alerts when important news are released.